Menstrual Cycle
Conditions
Keywords
Anesthetic Consumption, Luteal Phase, Follicular Phase, Postoperative Nausea and Vomiting
Brief summary
This prospective observational cohort study aims to evaluate the association between menstrual phase (determined by postoperative serum progesterone levels), intraoperative anesthetic consumption, and the incidence and severity of postoperative nausea and vomiting (PONV) in female patients undergoing cholecystectomy. Intraoperative anesthetic requirements will be recorded, and postoperative nausea and vomiting will be assessed using standardized scoring systems.
Detailed description
Hormonal fluctuations during the menstrual cycle may influence anesthetic requirements and susceptibility to postoperative nausea and vomiting (PONV). However, the relationship between menstrual phase and intraoperative anesthetic consumption remains unclear. This prospective observational cohort study will include female patients undergoing elective cholecystectomy under general anesthesia. No intervention will be applied beyond standard clinical practice. Intraoperative anesthetic drug consumption will be recorded quantitatively. Postoperative nausea and vomiting will be evaluated during the early postoperative period using validated assessment tools.
Interventions
None listed
Sponsors
Ankara Etlik City Hospital
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Female patients aged 18 to 65 years * American Society of Anesthesiologists (ASA) physical status I-II-III * Scheduled for elective laparoscopic cholecystectomy under general anesthesia * Willing and able to provide written informed consent
Exclusion criteria
* Age outside the specified range (younger than 18 or older than 65 years) * Male patients * American Society of Anesthesiologists (ASA) physical status ≥ IV * Severe systemic comorbidities (e.g., significant cardiovascular, hepatic, renal, or pulmonary disease) * Conversion from laparoscopic to open cholecystectomy * History of alcohol, drug, or substance abuse * Visual or hearing impairment interfering with study assessments * Current hormone replacement therapy * Use of oral contraceptives * Preoperative nausea or vomiting * History of severe postoperative nausea and vomiting * Neurological or psychiatric disorders affecting assessment reliability * Hemodynamic instability during surgery * Postoperative admission to intensive care unit * Acute cholecystitis at the time of surgery * Refusal to participate or inability to provide informed consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Intraoperative Anesthetic Agent Consumption | From induction of anesthesia to the end of surgery | Total amount of anesthetic agents administered during surgery, recorded quantitatively (e.g., mg of intravenous agents and/or minimum alveolar concentration-hours of volatile anesthetics). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Perioperative Hemodynamic Changes | From induction of anesthesia until the end of surgery | Changes in mean arterial pressure recorded intraoperatively at predefined time intervals. |
| Postoperative Vomiting | Within 24 hours after surgery | Incidence of vomiting episodes recorded during the postoperative period. |
Countries
Turkey (Türkiye)
Contacts
CONTACToya Çimen, Specialist in Anesthesiology
CONTACTFethi Gültop, Specialist in Anesthesiology
PRINCIPAL_INVESTIGATORoya çimen, Specialist in Anesthesiology
Ankara Etlik City Hospital
Outcome results
None listed